Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $9.64 | Change: +$0.79 | %Change: +8.93%
Volume: 172,460 | Day High/Low: 9.80/8.86 | 52 Week High/Low: 8.98/2.40
View modes: 
0 stars

RE:RE:RE:Major Biotech Conference starts next Monday

Thanks! Exposure & awareness is paramount for this emerging innovation should it become commercially viable. WF10 seems to me a promising innovation for allergic rhinitis.  rate and reply
0 stars

RE:RE:RE:Major Biotech Conference starts next Monday

They intend to use their time there well. They will be focussing on those Venture capital reps for specilaized biotech investors from Wall Street..  rate and reply
0 stars

RE:RE:Major Biotech Conference starts next Monday

Yes. Presenting as well. Their WF10 commentary will be interesting. Maybe a hint at what they already know?  rate and reply
0 stars

RE:Major Biotech Conference starts next Monday

Haven't heard if NRI is presenting in this Major Biotech Conference. Is there anyone who can confirm this. It will be highly appreciated on this board. Thanks  rate and reply
1.5 stars

RE:RE:Insiders still aquiring more

grant of rights grant of rights noun authorization, bestowal of authority, ceding of authority, conveyance of authority, conveyance of rights, grant of authority, transfer of rights  rate and reply
1 star

RE:Insiders still aquiring more

According to the "TMX" site an "Insider" has been "selling" the last couple of days... Another, almost 2000 shares yesterday, to go with the 6500 shares the previous day... (Shows up on TDW more
5 stars

Insiders still aquiring more

According to "Canadian Insider", the insiders appear to be exercising their "Rights" and exchanging them for shares. Always good to see the insiders putting their own money into this. The more " more
0 stars

A little more After Hours activity again today on the OTC

6.00  -0.06 (-0.96%) After Hours: 6.01 +0.01 (0.22%) OTCMKTS:NRIFF  rate and reply
0 stars

Up on the OTC but down on the TSX

will be interesting to see how she closes today. NRIFF: 6.11  +0.05 (0.86%) TSX: 7.07  -0.07 (-0.98%)  rate and reply
2.5 stars

Nadaq PP

My guess is a Nasdaq listing and PP as early as next week at a bs per share price based on a 60 day average. That's how I read the situation and trading since mid - Nov. All just my opinion.  rate and reply
4 stars

Major Biotech Conference starts next Monday

It seems, in anticipation of the presentation impact, investors are buying in early . It will be interesting to see if volumes on the US listing will increase.  rate and reply
3 stars

RE:RE:RE:The science base for WF10

As far as i am concerned, when a company hires an "IR Firm" it is a red flag for me.  Investor Relations (IR) assists companies of all market caps reach the highest and most appropriate more
3 stars

RE:RE:The science base for WF10

As far as i am concerned, when a company hires an "IR Firm" it is a red flag for me. Seems to me there is a lot of unverified streched hype going on here.  Two blocks of 50k were traded after hours more
4 stars

RE:The science base for WF10

WC - thank you.  I am not in biology so all this is over my head.  But I am getting to a somewhat diffeennt point,  Sure articlaes all over the place.  Isnt the high value process to actually have more
5 stars

The science base for WF10

Below is a link you copy and paste to get to a Google search for WF10. It has the citations and abstracts for over 30 articles from reputable medical and science journals on a wide array more
2 stars

RE:Another pipeline potential

  rate and reply
2 stars

Another pipeline potential

Penecure  is listed on the site Evalute which states Nuvo is searching for partners for distribution . Another market entry we have to share part of  1Billion /year category to treat nail more
5 stars


Peterstock, Yes I would expect that hedge funds and investment firms have science specialists as advisors on the viability of new biotech preducts, in terms of ability to get approval (if they more
0 stars


Thanks Rock et al,  However this seems backwrd.  PHDs are hired by investment firms to assess these businesses.  Fine.  So if you know this the surely management knows it.  Seems like more
3.5 stars

WF10 - More than an Investment to me

I'm confident that NRI is going to change my life in more than one way with WF10. Can't wait for the day when I'll be able to sit outside (counting my cash) and watch my wife mow the lawn :) more